May 20, 2021 02:51 PM EDTUpdated May 21, 01:58 PM
R&D
FDA+

FDA re­vis­es and ex­pands draft guid­ance on ad­just­ing for co­vari­ates in RCTs

Zachary Brennan

Senior Editor

The FDA on Thurs­day re­vised and ex­pand­ed a 2019 draft guid­ance that spells out how to ad­just for co­vari­ates in the sta­tis­ti­cal analy­sis of ran­dom­ized …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times